"The U.S. Food and Drug Administration today approved the first generic versions of Celebrex (celecoxib) capsules, a treatment for rheumatoid arthritis, osteoarthritis, short-term (acute) pain, and other conditions.
Teva Pharmaceutical Indus"...
In a clinical study, 5 patients received single infusions of up to 1000 mg of SIMPONI ARIA without serious adverse reactions or other significant reactions.
None.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 8/17/2015
Additional Simponi Aria Information
Report Problems to the Food and Drug Administration
Get the latest treatment options